1. Home
  2. CMND vs APDN Comparison

CMND vs APDN Comparison

Compare CMND & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMND
  • APDN
  • Stock Information
  • Founded
  • CMND 2017
  • APDN 1983
  • Country
  • CMND Canada
  • APDN United States
  • Employees
  • CMND N/A
  • APDN N/A
  • Industry
  • CMND Biotechnology: Pharmaceutical Preparations
  • APDN Other Consumer Services
  • Sector
  • CMND Health Care
  • APDN Consumer Discretionary
  • Exchange
  • CMND Nasdaq
  • APDN Nasdaq
  • Market Cap
  • CMND 4.8M
  • APDN 4.2M
  • IPO Year
  • CMND N/A
  • APDN N/A
  • Fundamental
  • Price
  • CMND $0.85
  • APDN $4.98
  • Analyst Decision
  • CMND
  • APDN
  • Analyst Count
  • CMND 0
  • APDN 0
  • Target Price
  • CMND N/A
  • APDN N/A
  • AVG Volume (30 Days)
  • CMND 122.4K
  • APDN 129.1K
  • Earning Date
  • CMND 06-12-2025
  • APDN 08-07-2025
  • Dividend Yield
  • CMND N/A
  • APDN N/A
  • EPS Growth
  • CMND N/A
  • APDN N/A
  • EPS
  • CMND N/A
  • APDN N/A
  • Revenue
  • CMND N/A
  • APDN $3,790,616.00
  • Revenue This Year
  • CMND N/A
  • APDN $57.08
  • Revenue Next Year
  • CMND N/A
  • APDN $40.00
  • P/E Ratio
  • CMND N/A
  • APDN N/A
  • Revenue Growth
  • CMND N/A
  • APDN N/A
  • 52 Week Low
  • CMND $0.80
  • APDN $4.37
  • 52 Week High
  • CMND $2.30
  • APDN $2,655.00
  • Technical
  • Relative Strength Index (RSI)
  • CMND 41.60
  • APDN 29.27
  • Support Level
  • CMND $0.83
  • APDN $4.44
  • Resistance Level
  • CMND $0.93
  • APDN $5.50
  • Average True Range (ATR)
  • CMND 0.06
  • APDN 0.56
  • MACD
  • CMND 0.00
  • APDN 0.46
  • Stochastic Oscillator
  • CMND 32.64
  • APDN 7.42

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: